Neurology Central

Alzheimer’s disease: hormone therapy linked to small risk increase

A research team in Finland has revealed that long-term use of oral hormone therapy may be associated with a small increased risk of Alzheimer’s disease in postmenopausal women.

The researchers have stressed that the absolute risk is small (9–18 extra cases per 10,000 women per year) and the age at which hormone therapy is started has no bearing on future risk.

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.